Group 1 - The core viewpoint of the news is that Furuimei Medical has seen a continuous increase in its stock price, rising 12.72% over the last four days, with a current price of 81.50 yuan per share and a market capitalization of 21.596 billion yuan [1] - Furuimei Medical, established on December 26, 2001, and listed on January 20, 2010, is primarily engaged in the production and sales of drugs in the liver disease sector, as well as instrument research and sales, and medical services [1] - The company's revenue composition is as follows: 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - According to data from the top ten holdings of funds, Chunhou Fund has a significant position in Furuimei Medical, with its Chunhou Times Preferred Mixed A Fund (014235) holding 10,000 shares, representing 3.78% of the fund's net value [2] - The Chunhou Times Preferred Mixed A Fund has generated a floating profit of approximately 9,200 yuan during the four-day price increase, with a current year-to-date return of 5.29% and a one-year return of 36.62% [2] - The fund manager, Chen Yin, has been in position for 185 days, with the fund's total asset size at 19.6662 million yuan, achieving a best return of 32.27% and a worst return of 31.96% during his tenure [3]
福瑞医科股价连续4天上涨累计涨幅12.72%,淳厚基金旗下1只基金持1万股,浮盈赚取9.2万元